147 related articles for article (PubMed ID: 9831927)
1. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
Best L; Benington S
Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glucose-induced electrical activity in rat pancreatic beta-cells by DCPIB, a selective inhibitor of volume-sensitive anion currents.
Best L; Yates AP; Decher N; Steinmeyer K; Nilius B
Eur J Pharmacol; 2004 Apr; 489(1-2):13-9. PubMed ID: 15063150
[TBL] [Abstract][Full Text] [Related]
3. Evidence that glucose-induced electrical activity in rat pancreatic beta-cells does not require KATP channel inhibition.
Best L
J Membr Biol; 2002 Feb; 185(3):193-200. PubMed ID: 11891577
[TBL] [Abstract][Full Text] [Related]
4. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
Lee K; Ozanne SE; Hales CN; Ashford ML
Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of tenidap on the volume-regulated anion channel and K(ATP) channel activity in rat pancreatic beta-cells.
Best L; Brown PD; Sener A; Malaisse WJ
Eur J Pharmacol; 2010 Mar; 629(1-3):159-63. PubMed ID: 20035738
[TBL] [Abstract][Full Text] [Related]
6. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition.
Fujitani S; Okazaki K; Yada T
Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence microscopy studies with a fluorescent glibenclamide derivative, a high-affinity blocker of pancreatic beta-cell ATP-sensitive K+ currents.
Zünkler BJ; Wos-Maganga M; Panten U
Biochem Pharmacol; 2004 Apr; 67(8):1437-44. PubMed ID: 15041461
[TBL] [Abstract][Full Text] [Related]
8. Tolbutamide potentiates the volume-regulated anion channel current in rat pancreatic beta cells.
Best L; Davies S; Brown PD
Diabetologia; 2004 Nov; 47(11):1990-7. PubMed ID: 15565369
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
[TBL] [Abstract][Full Text] [Related]
10. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
[TBL] [Abstract][Full Text] [Related]
11. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
Zünkler BJ; Lenzen S; Männer K; Panten U; Trube G
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):225-30. PubMed ID: 2452991
[TBL] [Abstract][Full Text] [Related]
12. Glucose and alpha-ketoisocaproate induce transient inward currents in rat pancreatic beta cells.
Best L
Diabetologia; 1997 Jan; 40(1):1-6. PubMed ID: 9028711
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a swelling-activated anion conductance in homozygous typing cell hepatoma cells.
Bodily K; Wang Y; Roman R; Sostman A; Fitz JG
Hepatology; 1997 Feb; 25(2):403-10. PubMed ID: 9021954
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of glucose-stimulated beta-cell activity by an anion channel inhibitor.
Best L; Brown PD; Sheader EA; Yates AP
J Membr Biol; 2000 Sep; 177(2):169-75. PubMed ID: 11003691
[TBL] [Abstract][Full Text] [Related]
15. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers.
Ballatori N; Truong AT; Jackson PS; Strange K; Boyer JL
Mol Pharmacol; 1995 Sep; 48(3):472-6. PubMed ID: 7565627
[TBL] [Abstract][Full Text] [Related]
16. Relationships between the Na(+)/K(+) pump and ATP and ADP content in mouse pancreatic islets: effects of meglitinide and glibenclamide.
Elmi A; Idahl LA; Sehlin J
Br J Pharmacol; 2000 Dec; 131(8):1700-6. PubMed ID: 11139449
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
Tian YA; Johnson G; Ashcroft SJ
Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
[TBL] [Abstract][Full Text] [Related]
18. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
[TBL] [Abstract][Full Text] [Related]
19. The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide.
Matthews EK; Shotton PA
Br J Pharmacol; 1984 Jul; 82(3):689-700. PubMed ID: 6430377
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
